Fingerstick Precision and Total Error of a Point-of-Care HbA1c Test

J Diabetes Sci Technol. 2020 Sep;14(5):890-895. doi: 10.1177/1932296819831273. Epub 2019 Mar 6.

Abstract

Background: Point-of-care (POC) HbA1c tests hold the promise of reducing the rates of undiagnosed diabetes, provided they exhibit acceptable analytical performance. The precision and total error of the POC (Afinion™ HbA1c Dx) test were investigated using whole blood samples obtained by fingerstick and venipuncture.

Methods: Fingerstick samples spanning the assay range were collected from 61 subjects at three representative POC sites. At each site, six fingerstick samples were obtained from each subject and tested on the POC test across two (Afinion AS100) instruments. Repeatability, between-operator, and between-instrument components of variance were calculated using analysis of variance (ANOVA). Four venous samples (low, threshold, medium, and high HbA1c) were measured in duplicate across three instruments using three reagent lots, twice per day over 20-days. Repeatability, between-run, between-day, between-lot, and between-instrument components of variance were calculated. These fingerstick and venous blood results, combined with estimates of imprecision and bias from a prior investigation, allowed for the calculation of the total coefficient of variation (CV) and total error of the POC test using fingerstick and venous whole blood samples.

Results: The total imprecision ranged from 1.30% to 2.03% CV using fingerstick samples and from 1.31% to 1.64% CV using venous samples. The total error ranged from 2.87% to 4.75% using fingerstick samples and from 2.93% to 3.80% using venous samples.

Conclusions: The POC test evaluated here is precise across its measuring range using both fingerstick and venous whole blood. The calculated total error of the test is well under the accepted quality requirement of ≤6%.

Keywords: HbA1c; diagnosis of diabetes; hemoglobin A1c; point of care; precision; total error.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / blood
  • Blood Chemical Analysis*
  • Diabetes Mellitus / blood
  • Diabetes Mellitus / diagnosis*
  • Glycated Hemoglobin / analysis*
  • Humans
  • Point-of-Care Systems*
  • Point-of-Care Testing*
  • Predictive Value of Tests
  • Reproducibility of Results
  • United States

Substances

  • Biomarkers
  • Glycated Hemoglobin A
  • hemoglobin A1c protein, human